Bio-Rad Laboratories Inc. - Ordinary Shares - Class A
BIO
Market Cap$0
Close$
$108.26
55.1% downside
Current Fair Value
55.1% downsideOvervalued by 55.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | - |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-65.36 |
| Beta | 1 |
| Outstanding Shares | 27,941,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.96 |
|---|---|
| PEG | 2.96 |
| Price to Sales | 2.68 |
| Price to Book Ratio | 1.01 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | - |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Bio-Rad Laboratories Inc.
CEO: Norman Schwartz